Chaim Hurvitz

Insider Reports History

Entity
Individual
Location
C/O Galmed Pharmaceuticals Ltd., 8 Shaul, Hamelech Blvd, Amot Hamishpat Bldg., Tel Aviv, Israel
Signature
/s/ Chaim Hurvitz
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Chaim Hurvitz:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NRX Pharmaceuticals, Inc. Director Common Stock, par value $0.001 per share 1.44M $459K $0.32 Aug 30, 2023 By Shirat HaChaim Ltd.
NRX Pharmaceuticals, Inc. Director Common Stock, par value $0.001 per share 570K $182K $0.32 Aug 30, 2023 Direct
NRX Pharmaceuticals, Inc. Director Common Stock, par value $0.001 per share 208K $66.7K $0.32 Aug 30, 2023 By CH Health-Private Venture Capital Ltd.
Dror Ortho-Design, Inc. Director Common Warrants 42.4M Aug 14, 2023 Indirect
Dror Ortho-Design, Inc. Director Stock Option (Right to Buy) 21.1M Jun 17, 2024 Direct
Dror Ortho-Design, Inc. Director Series A Convertible Preferred Stock 592K Aug 14, 2023 Indirect

Insider Reports Filed by Chaim Hurvitz

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DROR Dror Ortho-Design, Inc. Jun 17, 2024 1 $78.2K 4 Jun 25, 2024 Director
NRXP NRX Pharmaceuticals, Inc. Aug 30, 2023 1 $20.1K 4 Sep 11, 2023 Director
NVNT Dror Ortho-Design, Inc. Aug 14, 2023 2 $0 4 Sep 27, 2023 Director
NRXP NRX Pharmaceuticals, Inc. Oct 21, 2022 3 $515K 4/A Nov 23, 2022 Director
NRXP NRX Pharmaceuticals, Inc. May 24, 2021 3 $0 4 Jun 10, 2021 Director
NRXP NRX Pharmaceuticals, Inc. May 24, 2021 0 $0 3 Jun 10, 2021 Director